行情

RMTI

RMTI

罗克韦尔医药
NASDAQ

实时行情|Nasdaq Last Sale

1.670
-0.010
-0.60%
休市 16:00 08/07 EDT
开盘
1.670
昨收
1.680
最高
1.700
最低
1.610
成交量
46.46万
成交额
--
52周最高
3.850
52周最低
1.306
市值
1.15亿
市盈率(TTM)
-3.1426
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测RMTI价格均价为10.00,最高价位11.00,最低价为9.00。

EPS

RMTI 新闻

更多
Rockwell Medical to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights
WIXOM, Mich., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today ann
GlobeNewswire · 4天前
MU, SPG among premarket gainers
Seeking Alpha - Article · 06/30 12:21
Does Rockwell Medical (NASDAQ:RMTI) Have A Healthy Balance Sheet?
Simply Wall St. · 06/17 13:43
Rockwell Medical, Inc. Appoints Dr. Allen R. Nissenson to Board of Directors
WIXOM, Mich., June 10, 2020 -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia.
GlobeNewswire · 06/10 20:30
Hedge Funds Watching Rockwell Medical Inc (RMTI) From Afar
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. I
Insider Monkey · 05/27 16:43
Rockwell Medical files NDS for Triferic AVNU in Canada
Rockwell Medical (NASDAQ:RMTI) has filed a New Drug Submission (“NDS”) with Health Canada for Triferic AVNU (ferric pyrophosphate citrate). The Company see
seekingalpha · 05/26 16:20
Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic® AVNU™
WIXOM, Mich., May 26, 2020 -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia.
GlobeNewswire · 05/26 11:00
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/12 01:54

所属板块

生物技术和医学研究
-0.18%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

RMTI 简况

Rockwell Medical Inc是一家生物制药公司。该公司专注于晚期肾脏疾病和慢性肾脏疾病,其产品用于治疗缺铁和血液透析。该公司同时也为透析供应商和分销商生产血液透析浓缩液。该公司的肾脏药物治疗方法Triferic,对疾病管理初期有作用。Triferic的目的是在每次透析治疗时,通过透析液来替换血液透析病人的铁,同时维持血红蛋白。该公司已经开发了多种配方的Triferic治疗方法:透析液Triferic和静脉内Triferic(I.V. Triferic)。透析液Triferic是用于替换铁和维持血液透析病人血红蛋白的治疗方法。
展开

微牛提供Rockwell Medical Inc(NASDAQ-RMTI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的RMTI股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易RMTI股票基本功能。